
|Videos|July 21, 2020
Building Global Antibiotic Resistance Monitoring Capacities
Author(s)Grant M. Gallagher
Dr. Pol Vandenbroucke explains how the development of health and civil society infrastructure around the world helps to slow antimicrobial resistance.
Advertisement
Segment Description: Dr. Pol Vandenbroucke, Chief Medical Officer for Pfizer’s hospital business unit, describes efforts to build up capacity for antimicrobial resistance surveillance in low- and middle-income countries. Dr. Vandenbroucke also explains how the development of both health and civil society infrastructure around the world helps to slow antimicrobial resistance.
Newsletter
Stay ahead of emerging infectious disease threats with expert insights and breaking research. Subscribe now to get updates delivered straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contagion Live
1
Interpreting FDA’s Request for Warning Labels on Influenza Vaccines About Febrile Seizures
2
HIV Spending for Fiscal Year 2026: The Latest Update
3
Measles Update: January 30, 2026
4
FDA Clears MicuRx’s IND for MRX-5, Paving the Way for Phase 2a Trial in Hard-to-Treat NTM Lung Disease
5

































































































































